RMTI250516P7500
- 0.00
- 0.000.00%
Rockwell Medical Newsroom
Press Release: Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025
Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Here's Why Rockwell Medical (NASDAQ:RMTI) Can Manage Its Debt Responsibly
H.C. Wainwright Maintains Rockwell Medical(RMTI.US) With Buy Rating, Cuts Target Price to $3
Rockwell Medical Is Maintained at Buy by HC Wainwright & Co.
Rockwell Medical Analyst Ratings
Rockwell Medical's Growth Potential Amid Revenue Challenges: A Buy Rating by Ram Selvaraju
Express News | Rockwell Medical, Inc. : H.c. Wainwright Cuts Target Price to $3 From $7
Why Rockwell Medical Inc. (RMTI) Went Down On Thursday?
Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Could Be 36% Below Their Intrinsic Value Estimate
Rockwell Medical Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Rockwell Medical, Inc. (NASDAQ:RMTI) Not Doing Enough For Some Investors As Its Shares Slump 26%
Rockwell Medical Reports Record Sales and Profitability
Earnings Call Summary | Rockwell Medical(RMTI.US) Q4 2024 Earnings Conference
Rockwell Medical Shares Are Trading Lower. The Company Reported Q4 Financial Results.
Express News | Rockwell Medical Shares Are Trading Lower. The Company Reported Q4 Financial Results
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Rockwell Medical | 10-K: FY2024 Annual Report
Rockwell Medical | 8-K: Rockwell Medical Announces Fourth Quarter and Full-Year 2024 Financial and Operational Results